Yafang Deng

Yafang Deng

Auto-generated profile, based on publicly available information

Yafang Deng

School of Medicine Tsinghua Medicine, Tsinghua University Beijing China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in Journal of Molecular Biology
Verified
Journal Article
Closed access
FZFan Zhao
Fan Zhao
YDYafang Deng
Yafang Deng
FYFen Yang
Fen Yang
YYYan Yan
Yan Yan
FFFan Feng
Fan Feng
HLHaitao Li
Haitao Li

7 March 2025 in Protein & Cell
Verified
Journal Article
Open access
WLWei Liu
Wei Liu
XZXiulan Zhang
Xiulan Zhang
YDYafang Deng
Yafang Deng
DWDaliang Wang
Daliang Wang
HLHaitao Li
Haitao Li

17 January 2025 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
YDYafang Deng
Yafang Deng
LQLin Qiao
Lin Qiao
HLHongbin Li
Hongbin Li
CYChen Yu
Chen Yu
SJShangyi Jin
Shangyi Jin
Xinping TianXinping Tian
Xinping Tian

11 September 2025 in Pediatric Investigation
Verified
Journal Article
Open access
YDYafang Deng
Yafang Deng
QGQiang Gao
Qiang Gao
WZWei Zhang
Wei Zhang
Importance: Brain and central nervous system (CNS) cancers are the most common pediatric solid tumors, significantly affecting the patients’ life expectancy and quality. Objective: To examine the disease burden of brain and CNS cancer in children and adolescents from 1990 to 2021 across various age groups, sexes, and socio‐demographic index levels, at the global, regional, and national levels. Methods: Data, including the incidence, mortality, and disability‐adjusted life years (DALYs) of brain and CNS cancer in children and adolescents, were obtained from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study. Temporal trends were evaluated using the Joinpoint regression model. The relationship between disease burden and socioeconomic development, as well as health inequality, was examined. Results: In 2021, the global age‐standardized incidence rate of brain and CNS cancers among patients aged 0–20 years was 1.55 per 100 000 population. From 1990 to 2021, the global age‐standardized mortality rate (ASMR) declined from 1.14 to 0.76 per 100 000, and the age‐standardized DALY rate (ASDR) decreased from 94.29 to 62.79 per 100 000. Over the past three decades, most regions and countries and territories have shown declining trends in ASMR and ASDR. Global inequality of disease burden persists, with regions possessing higher socioeconomic statuses exhibiting lower ASMR, ASDR, and mortality‐to‐incidence ratio. Interpretation: The decline in ASMR and ASDR of pediatric brain and CNS cancer indicates improvements in disease management and patient outcomes. Enhancing diagnostic and therapeutic strategies, improving life quality, and promoting health equity are crucial directions for future research.